IAPAM Announces First of its 2014 Symposium Dates: February 8-9, 2014

The IAPAM's guiding principle is enRICHing Physicians Lives, and its goal is to support physicians who are seeking business education, may be over their heads with student debt and now, with reduced insurance reimbursements, are looking for cash-based modalities to add to their practices and to add to their bottom lines. To address this need, the IAPAM's Aesthetic Medicine Symposium was specifically designed as a "one-stop" program to add non-insurance based medical procedures to a practice, or to start a new medspa. The IAPAM announces the first of its 2014 dates for its respected Aesthetic Medicine Symposium with botox training, in Scottsdale, Arizona: February 8-9.

Las Vegas, Nevada, USA (December 17, 2013) -- Lower insurance reimbursements are causing pain points for the physicians, and they are looking for other sources of revenue, just to break even. To support physicians seeking training in aesthetic modalities, the IAPAM's Aesthetic Medicine Symposium was designed to give physicians all the information, forms, DVDs, hands-on training, etc. that they need to begin offering aesthetics when they finish the conference. As well, it is important to understand that botox is not a profit centre, just a gateway to make money with other aesthetic procedures. Only the IAPAM's Symposium teaches physicians about this principle ..... no one else is offering this competitive intelligence.

The IAPAM is the only complete program that offers:

An Accelerated program; physicians and their staff can be certified over a weekend;
Clinical training DVD's to take back to one's practice;
Board certified Dermatologists as instructors;
Internationally recognized Certification;
CME (Continuing Medical Education) credits;
1 Year practice support (continues as long as a member); and much, much, more!

"More patients are turning to the more inexpensive non-invasive procedures rather than surgical cosmetic procedures," says Jeff Russell, Executive Director of the International Association for Physicians in Aesthetic Medicine (http://www.iapam.com). "They may not get the long term benefits of a face lift, but with a combination treatment of botox and dermal fillers, then can get a great result at a fraction of the price."

For more information on the IAPAM's February 8-9, 2014 Symposium with Botox Training, watch this comprehensive video at http://youtu.be/bBQlS0CpOvw or to register for the February 8-9 Aesthetic Medicine Symposium, please contact the IAPAM, at 1-800-219-5108 ext. 704, or visit http://www.iapam.com/aesthetic-medicine-symposium-botox-training.

Botox is a trademark of Allergan, Inc.

About the IAPAM: The International Association for Physicians in Aesthetic Medicine
The International Association for Physicians in Aesthetic Medicine is a voluntary association of physicians and supporters, which sets standards for the aesthetic medical profession. The goal of the association is to offer education, ethical standards, credentialing, and member benefits. IAPAM membership is open to all licensed medical doctors (MDs), dentists (DDSs/DMDs) doctors of osteopathic medicine (DOs), physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: Botox training, medical aesthetic training, laser for hair removal and training, laser tattoo removal training, physician hCG training, and aesthetic practice business training. Additional information about the association can be accessed through the IAPAM's website (http://www.iapam.com) or by contacting:

Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 x704

Output Factory Server for Adobe InDesign Is Now a 64-bit Application

Zevrix Solutions announces Output Factory Server 1.0.4, a maintenance update to its output workflow automation solution for Adobe InDesign. Output Factory Server automates printing and exporting from InDesign by processing files from watched hot folders and is a major upgrade of the company's program BatchOutput Server. The new version makes Output Factory Server a fully 64-bit native application, thus improving its performance and reducing the likelihood of memory-related errors.

Toronto (ON), Canada (December 17, 2013) -- Zevrix Solutions today announces the release of Output Factory Server 1.0.4, a maintenance update to its solution to automate printing, exporting and post-processing from Adobe InDesign. Developed originally for a major magazine publisher in the United States to free up their operator computers from outputting InDesign files, the software automates InDesign workflow by processing files from watched hot folders.

The new version makes Output Factory Server a fully 64-bit native application, thus improving its performance and reducing the likelihood of memory-related errors. One of the main advantages of 64-bit support for the users is the ability to create images from oversized InDesign documents at high resolution. In previous versions, exporting a large InDesign document as a TIFF image of over 500 MB in size could lead to memory-related errors.

"Output Factory Server is an extremely useful utility for a busy production facility or advertising agency", writes David Creamer in Layers magazine, "It can save lots of time - which equates to money."

Output Factory Server offers the following key features:

-Support for printing, PDF, PostScript, EPS, JPEG, Flash, EPUB and other formats
-Layer versioning: output specific layers and their combinations as single files
-Update modified links automatically
-Variable output file names
-Preflight files before output
-Automatic e-mail notifications of process stages and errors

Output Factory Server also allows for a single set of output settings for an entire workgroup, solving problems caused by inconsistent settings across workstations and dramatically simplifying support tasks.

Pricing and Availability:
Output Factory Server can be purchased from Zevrix web site for US$699.95, as well as from authorized resellers. Trial is also available for download. BatchOutput Server users can upgrade for $349.97. Output Factory Server runs on Mac OS X 10.6-10.9 and works with Adobe InDesign CS3-CC.

About Zevrix Solutions

Located in Toronto, Canada, Zevrix Solutions provides productivity solutions for Adobe Creative Suite software, PDF and graphic file diagnostics, file delivery and Microsoft Office on Mac OS. Zevrix Solutions is dedicated to helping professionals achieve more while doing less through automating their everyday tasks, producing error-free documents, saving disk space and cutting production costs. For more information, visit http://www.zevrix.com.

Contact:
Leo Revzin
Owner
Zevrix Solutions
105 McCAUL St, Suite 301
Toronto Ontario M5T 2X4 Canada
858-206-0607

IAPAM Announces Newest Date for Physician hCG Training: February 7, 2014

Lower insurance reimbursements are causing pain points for physicians, and they are looking for other sources of revenue, just to break even. To support these physicians, the IAPAM announces the first of its 2014 dates for its respected Physician hCG Training seminar: on February 7, 2014 in Scottsdale, AZ.

Las Vegas, Nevada, USA (December 17, 2013) -- Soon it will be the New Year and patients will be flooding their physicians' offices looking for safe and effective diet or medical weight management options. 50% of all New Years' Resolutions are to lose weight!

To support physicians in adding a medical weight management program to their practices, like hCG for weight loss (the hCG diet), the IAPAM (http://www.iapam.com) has developed the Clean Start hCG Weight Loss Program to assist physicians in helping their obese and overweight patients realize their weight loss goals.

It is a comprehensive and complete weight loss program that includes:

- Detailed Clean Start hCG Program Protocols
- Patient selection criteria
- Common medical hCG contraindications
- Consent forms, medical history forms
- Patient PowerPoint presentations for the waiting room
- Phone scripts & call logs for your staff
- Legal/Insurance considerations, and current FDA status
- hCG ordering information and special pharmaceutical hCG pricing
- Special hCG Facebook discussion forum
- VLCD/LCD diet programs
- Meal replacement diet programs
- Ketogenic based diet programs
- Utilizing B6/B12 injections in weight loss
- Using prescription appetite suppressants in weight loss
- Metabolism testing as a profit center
- Non-invasive body contouring, using Radio Frequency (RF) energy
- Listing of one's hCG Clinic in the IAPAM's hCG Diet Clinic Directory

The IAPAM's Clean Start hCG for Weight Loss program includes physician training, physician materials, practice resources and patient tools. The Clean Start hCG for Weight Loss Patient Kit is a complete solution for one's hCG patients. This industry-leading resource includes:

Patient education DVD, that gives your patients an overview of the entire program, and answers the most common questions.
Patient Guidebook, that explains the program in detail, including over 50 program tips, as well as over 20 pages on the all important "maintenance" phase of the program. It includes information on: portion size, the Glycemic Index, how to read a nutritional label, tips on how to combat emotional eating and cravings.
Quick Tip Sheets giving your patient the most important tips and a take-away shopping list complete with calorie counts.
Cookbook with over 50 recipes for all 3 phases of the weight loss program.
Food Journal for your patients to record their daily food intake.

This patient tool was designed to answer the most common questions, saving physicians time, allowing them to see more patients, and generate more non-insurance based practice revenues.

What revenues can you expect to see by offering the IAPAM's Clean Start Weight Loss program?

See 10 weight loss patients/month = $176,000+/yr
See 20 weight loss patients/month = $352,000+/yr
See 30 weight loss patients/month = $529,000+/yr

With more than 60% of Americans overweight or obese, seeing 30 patients a month should not be a problem for most practices! The IAPAM's new hCG Training video (http://www.youtube.com/watch?v=d-YGEQ0t0yw) outlines the IAPAM's New Clean Start hCG Weight Loss program.

Register today for the February 7th, 2014 training session. To register or for more information, please visit http://www.iapam.com/physician-weight-loss-training-using-hormones or contact the IAPAM at 1-800-219-5108 ext 708.

About the IAPAM: The International Association for Physicians in Aesthetic Medicine
The International Association for Physicians in Aesthetic Medicine is a voluntary global association of physicians and supporters, which sets standards for the aesthetic medical profession worldwide. The goal of the association is to offer education, ethical standards, credentialing, and member benefits to members around the globe. IAPAM membership is open to all licensed medical doctors (MDs), doctors of osteopathic medicine (DOs), dentists (DDSs/DMDs) physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: botox training, medical aesthetic training, laser training, laser tattoo removal training, physician hCG training, and aesthetic practice business training.

Additional information about the association can be accessed through the IAPAM's website (http://www.iapam.com) or by contacting:

Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 ext. 708

Immigration Reform Amnesty Legislation Defeated for Next 3 Years by Americans

Immigration reform amnesty for illegal aliens has failed to pass in 2013 due to lobbying efforts from activists who represent the majority of American citizens opposed to such legislation and due to the political quagmires on the budget and healthcare.

Raleigh, NC, USA (December 17, 2013) -- Contact: Americans for Legal Immigration PAC (ALIPAC) (866) 703-0864, Press@alipac.us

Immigration reform amnesty for illegal aliens has failed to pass in 2013 due to lobbying efforts from activists who represent the majority of American citizens opposed to such legislation and due to the political quagmires on the budget and healthcare.

Americans for Legal Immigration PAC is announcing the Defeat of Amnesty 2013 which has been the national organization's year long focus and battle cry while also pointing out that immigration reform amnesty for illegal aliens is likely doomed for the next three years.

"The off election year of 2014 and the resulting loss of amnesty supporters who will be defeated by the public next year will shut down legislative amnesty, hopefully for three years!" said William Gheen, President of ALIPAC. "The invasion and amnesty supporters have made a big tactical mistake. We stopped them from getting their Amnesty bill to Obama's desk and now we know which Republicans and Democrats need to be thrown out of office in 2014."

ALIPAC is focusing attention on a list the group is circulating of 35 GOP members of Congress who have been detected secretly working with the Obama administration to pass amnesty for illegal aliens. Four incumbent GOP members of the Senate up for reelection in 2014 are similarly targeted for removal.

Removing lawmakers who support immigration reform amnesty from office will occur because a large majority of Americans do not support a path to citizenship for illegal aliens that would in turn create a new voting bloc of prior illegals in American elections which would permanently destroy all borders and immigration law enforcement. Speaker Boehner knows this and has told business leaders he will help Pelosi and Obama pass amnesty after filing closes in 2014.

While illegal alien invasion supporters tell the media they hope to eventually overwhelm American defenders through continued illegal immigration and very high birth rates among the new arrivals, and that they want Obama to increase his risk of impeachment by further violating the Constitution with decreed amnesty, ALIPAC is encouraged by this change in the tide of the struggle.

For more information about ALIPAC's fight against illegal immigration and amnesty or to access the lists of GOP lawmakers that need Republican primary challengers to defeat them in 2014 please visit http://www.alipac.us.

URALCHEM OJSC Reports Securing a Loan of US $4.5 Billion

URALCHEM has secured a loan of up to US $4.5 billion. The loan has been granted for a period of 84 months. A major part of the loan will be used to pay for the 20% of shares to be acquired in Uralkali.

Moscow, Russia (December 17, 2013) -- URALCHEM OJSC has secured a loan of up to US $4.5 billion. The loan has been granted for a period of 84 months.

URALHEM OJSC and the plant in Kirovo-Chepetsk are the borrowers in the transaction. VTB Capital Plc is acting as the lender, the loan agent and the documentation agent. The loan guarantees are Voskresensk Mineral Fertilisers, OJSC in Voskresensk, URALCHEM Trading House Ltd, OJSC Minudobrenia in Perm, URALCHEM HOLDING P.L.C. and SIA URALCHEM Trading.

Out of the $4.5 billion loan, a major part will be used to pay for the 20% of shares to be acquired in OJSC Uralkali. Part of the borrowed funds can be used to repay the current loan liabilities of the URALCHEM Group and will be called on if the existing creditors of the Group require early repayment of liabilities due to changes in the credit portfolio of the Group.

On 4 December 2013, URALCHEM Group's shareholders announced an agreement to acquire a package of shares and GDRs in OJSC Uralkali (MICEX-RTS: URKA; LSE: URKA), constituting 20% of total share capital of the company. Closure of the transaction is expected in the near future. These shares will be used as collateral for the loan borrowed from VTB Capital Plc.

PR Department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.

Art Gallery Names Gaylord Mink as Featured Artist

Light Space & Time Online Art Gallery is pleased to announce that Washington wildlife photographer Gaylord Mink has been named as the gallery's new featured artist.

Jupiter, FL, USA (December 15, 2013) -- Light Space & Time Online Art Gallery is pleased to announce that Washington wildlife photographer Gaylord Mink has been named as the gallery's new featured artist. Gaylord will now be in the gallery's Artist Showcase section and will be promoted by the gallery for the next 30 days.

Gaylord Mink was born in Indiana and he migrated to Washington where he was a research scientist for most of his adult life. When Gaylord was near retirement he made several trips to through eastern Africa where he became interested in nature and wildlife photography.

After retirement Gaylord took up still and video photography. For a short time he produced short videos mainly for educational purposes and in recent years he has concentrated mostly on still photography.

Gaylord says this about his art, "While the subject matter has varied greatly, one favorite subject has remained the herds of wild horses that roam the Yakama Reservation not too far away from where I live. I have exhibited some of the wildlife images at local events and some of these images hang in many local businesses. However, mostly I post images online to get the critical comments and suggestions necessary for self-improvement."

He goes on a states that, "Recently I have become intrigued with digital software to modify images in ways that create impressions and feelings quite apart from the originals. As a novice at art I am enjoying the experience of looking at my surroundings in new and interesting ways." Gaylord's art website is http://www.minkphotos.com.

About Light Space & Time Online Gallery

Light Space & Time Online Art Gallery offers monthly art competitions and monthly art exhibitions for new and emerging artists. Light Space & Time's intention is to showcase this incredible talent in a series of monthly themed art competitions and art exhibitions by marketing and displaying the exceptional abilities of these artists. Their online gallery website can be viewed here: http://www.lightspacetime.com.

Media Contact:
John R. Math
Light Space & Time Online Gallery
118 Poinciana Drive
Jupiter, FL 33458
888-490-3530

Zevrix File Transfer App Deliver Now Supports Mac OS X 10.9 Mavericks

Zevrix Solutions announces Deliver 2.4.6, a compatibility update to its automated file transfer solution for remote and local destinations. Deliver lets users send files to FTP, SFTP, Amazon S3, WebDAV and other servers and offers automatic e-mail notifications, delivery to multiple destinations, file encryption, delivery history and other powerful capabilities. The new version makes Deliver compatible with recently released Mac OS X 10.9 Mavericks.

Toronto (ON), Canada (December 13, 2013) -- Zevrix Solutions today announces Deliver 2.4.6, a compatibility update to its file transfer solution for remote and local destinations. Deliver lets users send files over Internet and local networks with automatic e-mail notifications, file compression, delivery history and other powerful capabilities. It supports FTP, SFTP, Amazon S3, WebDAV and other remote and local services, and allows to send files to multiple destinations at once.

The new version makes Deliver compatible with recently released Mac OS X 10.9 Mavericks and is offered as a free update to licensed users.

"Deliver gives plenty to like," writes Natalia Nowak on Mac360, a Mac app reviews site. "It's a secure document delivery system with tracking built in, and straightforward and comprehensive user interface."

Deliver simplifies and streamlines file delivery operations of ad agencies, printers, audio recording studios, video producers and legal offices worldwide. Users only need to drop files on the program's icon and they will be delivered automatically to the desired destinations with customizable e-mail confirmations issued upon delivery. Recipients can download the file using a link inserted automatically into notification e-mail.

Deliver offers the following key features:

-Hyperlink to file for instant download by recipients
-Compress files automatically (.zip/.dmg)
-Encrypt disk images with passwords
-Create lo-res PDF on the fly and attach to e-mail
-Delivery history

Pricing and Availability:
Deliver can be purchased from Zevrix website for US$19.95. Trial is also available for download. The update is free for licensed users of Deliver 2.x. Deliver requires Mac OS X 10.5-10.9.

About Zevrix Solutions

Located in Toronto, Canada, Zevrix Solutions provides productivity solutions for Adobe Creative Suite software, PDF and graphic file diagnostics, file delivery and Microsoft Office on Mac OS. Zevrix is dedicated to help professionals increase their profits through automating everyday tasks, producing error-free documents, saving disk space and cutting production costs. For more information, visit http://www.zevrix.com.

Contact:
Leo Revzin
Owner
Zevrix Solutions
105 McCAUL St, Suite 301
Toronto Ontario M5T 2X4 Canada
858-206-0607

Materials Sold into Smart Windows Sector to Reach $545 million in Revenue by 2019

NanoMarkets believes that the value of the coatings, glass and other materials used by the smart windows sector will grow to around $ 770 million by 2021.

Glen Allen, Virginia (December 12, 2013) -- Revenues from smart windows in buildings and vehicles are growing and according to a new report from NanoMarkets, an industry analysis firm, the value of the coatings, glass and other materials used by the smart (i.e., self-tinting) windows sector will be almost $ 545 million by 2019 growing to around $ 770 million by 2021. For more information on the report, "Smart Windows Materials Markets" please visit: http://www.nanomarkets.net/market_reports/report/smart_windows_materials_markets_2014_2021.

NanoMarkets has issued previous reports on smart windows, smart auto glass and mirrors within the past year. See http://www.nanomarkets.net/glass_glazing.

About the report:

In the past five years or so, smart (i.e. self-dimming) windows have taken off in both residential and commercial building markets. They are also increasingly used in automobiles and trucks. There are several different smart windows technologies, but all of them are materials plays in one way or another. NanoMarkets believes that, as a result, there are important opportunities for materials firms that are emerging from the smart windows "revolution."

In this report NanoMarkets discusses the opportunities for materials in smart windows and mirrors using electrochromic, photochromic, thermochromic, PDLC, SPD and microblinds. The forecasts and analysis cover not only the active smart materials used in these technologies, but also the substrate materials; both plastic and glass. The report contains revenue and volume (area) forecasts for each smart windows technology with breakouts by film, glass and coatings.

In addition, this report analyzes a number of different business models being used in the smart windows sector and shows how materials play into the total smart windows value chain. We also discuss the role of technology licensing, as well as direct supply of smart coatings and other materials to glass and windows firms.

The report also analyzes the materials-related strategies of leading firms in this space including: 3M, Asahi Glass, BASF, Chameleon Photochromic Smart Film, Chromogenics Coolkote, Corning, DuPont, Eastman Chemical/Solutia, GE, Gentex, Guardian Industries, Hitachi, NDFOS, NSG, Pleotint, PPG, Ravenbrick, Research Frontiers, Sage, Saint-Gobain, Scienstry, Southwall, Solvay, Suntek, SWITCH Materials, Toray, Transition Window Tint, US e-Chromics, and View.

From the report:

Electrochromic smart windows (including glass and film) will reach $445 million by 2019 making electrochromics the largest segment of the entire smart windows business. NanoMarkets believes this may have much to do with the fact that this sector can boast significant investment by influential firms such as Corning, GE and Saint-Gobain, and Seagate. Alternatives to the electrochromic materials platform do not have the same level of clout behind them.

Smart windows materials platforms that are alternatives to electrochromics may have a struggle ahead but can ultimately survive as niche technologies, successful in certain niches, primarily because of their price, switching speeds or suitability for use in privacy glass. For example, it is widely acknowledged that PDLC will be used almost exclusively for privacy glass. However, from the perspective of specialty chemical companies, these
non-electrochromic technologies represent only limited opportunities. They will consume relatively small amounts of active materials and will not be worth large investments.

Until smart windows technology fully matures, NanoMarkets believes the specialty chemical companies will bide their time, merely supplying research quantities of active materials to smart windows firms and not supporting any one kind of materials platform. By contrast the glass/film companies can be "arms dealers" and sell to all "sides," benefitting from the growth of smart windows as a whole. NanoMarkets expects the smart windows sector to consume $220 million in glass and film by 2019.

About NanoMarkets:

NanoMarkets tracks and analyzes emerging markets in energy, electronics and other area created by developments in advanced materials. The firm is a recognized leader in industry analysis and forecasts in the specialty chemicals industry and has been covering the smart windows sector for five years.

Visit http://www.nanomarkets.net for a full listing of NanoMarkets' reports and other services.

Media Contact:
Robert Nolan
NanoMarkets, LC
PO BOX 3840
Glen Allen, VA 23058
(804) 938-0030

URALCHEM, OJSC Reports IFRS Financial Results for the First Nine Months of 2013

- Revenue increased to 56.26 bln RUB, compared to 55.96 bln RUB in the first nine months of 2012.
- Operating profit amounted to 14.63 bln RUB, compared with 17.09 bln RUB in the first nine months of 2012.
- Adjusted EBITDA comprised 17.32 bln RUB, compared to 19.55 bln RUB in the first nine months of 2012.

Moscow, Russia (December 11, 2013) -- URALCHEM, OJSC (hereinafter URALCHEM Holding or the Company), the Russian holding company of the URALCHEM Group, one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its unaudited IFRS financial results for the first nine months of 2013*.

The Group’s Key Financial Figures for the first nine months of 2013 and 2012 (million RUB)

9 months 2013
9 months 2012
Year-on-year change, %
Revenue
56,264
55,956
1%
Gross profit
29,856
32,266
-7%
Gross profit margin
55%
60%

Operating profit
14,625
17,094
-14%
Operating profit margin
27%
32%

Net profit[1]
10,083
18,818
-46%
Net profit margin
19%
35%

Adjusted EBITDA
17,315
19,550
-12%
Adjusted EBITDA margin
32%
37%

Cash generated from operating activities
13,141
14,712
-6%
*Starting from the reporting period of the first nine months of 2013, the Group will announce consolidated financial statements of URALCHEM OSJC and its subsidiaries on a quarterly basis.

Dmitry Konyaev, CEO of URALCHEM, OJSC, commented on the Company's results for the first nine months of 2013, "In the second half of 2013 the global market situation took a downward turn for fertilizer producers. Despite the difficult market conditions, URALCHEM maintained its revenues at the level of 2012. The Company is one of the leaders in the nitrogen segment in terms of output of ammonia per production unit. It is actively upgrading facilities, seeking to reduce costs and developing production of high-margin niche products. Thanks to its chosen strategy, URALCHEM has continued to maintain a leading position in terms of margins, with the EBITDA margin at 32%. The Company has maintained its financial stability together with its ability to develop strategic operations, as confirmed, among other things, by successive improvements of loan terms provided by banks."

Financial Results

Revenue for the first nine months of 2013 grew to 56.26 bln RUB, compared to 55.96 bln RUB in the first nine months of 2012. Operating profit amounted 14.63 bln RUB, or 27% of revenue, compared with the operating profit of 17.09 bln RUB, or 32% of revenue, in the first nine months of 2012.

During the first nine months of 2013, adjusted EBITDA reached 17.32 bln RUB, compared to 19.78 bln RUB in the first nine months of 2012, a decrease of 12%.

The adjusted EBITDA margin for the first nine months of 2013 comprised 32% of revenue compared with 37% of revenue for the same period in 2012.

Markets

From the beginning of the year, there was a decrease in demand for ammonia from the industrial segment in East Asia and the producers of phosphate fertilizers in India and North Africa. Demand in the US decreased because of the late start of planting. Partially the market was offset by the decrease in production in Egypt, Trinidad and Saudi Arabia. Recovery began in early August. There was a decline in exports from Ukrainian enterprises, and on the other hand, lower prices provided for growing interest in procurement. Average quotes for ammonia in January-September 2013 amounted to $498 / ton, which is only 4% lower than in the same period in 2012 (FOB Yuzhny Port).

In early 2013, high seasonal demand in Europe and the United States, limited supply from Egypt, and low initial stock in the European market resulted in increased prices for urea. However, in mid-February, prices began to decline, reducing further until the end of the first half of the year. Importing countries were postponing purchases in anticipation of lower prices, while Chinese exporters were actively accumulating stock expecting the "export window". In the 2nd quarter there was a decrease in production in regions with high costs, namely in Romania and Ukraine. Amid rising purchases from India, Turkey and Latin America, there was a short period of stabilization in June. However, after then, prices continued to decline because of massive Chinese exports. Average quotes for urea in January-September 2013 amounted to $339 / ton, which is 17% lower than in the same period a year earlier (FOB The Baltic Sea).

Steady growth in quotations for ammonium nitrate at the beginning of the year was replaced by a fall in mid-March. In late May, prices stabilized, helped by turnarounds at factories in the CIS. By the end of the 2nd quarter, prices in the CIS received support from the industrial segment. During January-September 2013 quotes for ammonium nitrate averaged $291 / ton, which is 4.6 % lower than a year earlier (FOB, The Baltic Sea). Starting from late September, prices for ammonium nitrate began to recover due to reduced exports from Ukraine, as well as to the beginning of the purchase season in the domestic market of the CIS.

In the phosphate fertilizers segment there was a global decline in prices due to a lack of current demand. The main reason came from India, where high levels of stock, reduction of state subsidies and depreciation of the rupee against the dollar led to a significant reduction in imports. Importers in other regions changed their procurement tactics to just satisfy the current demand, playing on the falling market. Average DAP/MAP quotes for the three quarters of 2013 fell by 14.7 % compared with the previous year, reaching $481 / ton (FOB, The Baltic Sea). Low market activity is expected until the end of the year and in the first quarter of 2014.

Sales
Comparative sales figures of the URALCHEM Group for the nine months of 2013-2012 (thousand tonnes):
Name of product
9 months of 2013
9 months of 2012
Year-on-year change,%
Ammonium nitrate and its derivatives
1,642.3
1,576.0
4%
Urea
868.1
904.1
-4%
Ammonia
504.3
503.0
0%
Phosphate fertilizers
375.2
345.7
9%
NPK fertilizers
455.6
464.0
-2%
Other chemicals, including ammonium nitrate for industrial use
579.7
564.4
3%
Total
4,425.2
4,357.2
2%

Financial Situation

Cash generated from operating activities in the first nine months of 2013 amounted to 13.14 bln RUB, compared to 14.71 bln RUB in the same period of 2012.

As at 30 September 2013, the Company's net debt amounted to 23.531 bln RUB. The weighted average interest rate of the loan portfolio in the first nine months of 2013 equalled 4.5% annually compared to 5.8% annually during the same period in 2012.

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

Public Relations Department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89

URALCHEM is one of the largest producers of nitrogen and phosphate fertilizers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.2 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilizers and 0.5 million tonnes of urea. URALCHEM is the second largest ammonium nitrate producer in the world and number one in Russia. URALCHEM's key production assets include Kirovo-Chepetsk Chemical Works, OJSC in Kirovo-Chepetsk, Kirov region; Azot, OJSC in Berezniki, Perm region; Voskresensk Mineral Fertilizers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.

[1] The decline in net profit was due to the revaluation of the Company’s share in Minudobrenia (Perm) carried out in 2012, as well as to the negative impact of the difference in exchange rates in 2013 compared with 2012 (see Appendix).



Annex to the press release about the unaudited financial results for the first half of 2013
EBITDA is a profit / loss from financial and economic activities during the reporting period, before deduction of income tax on profits, income and interest costs, depreciation and amortization. "Adjusted EBITDA" is EBITDA for the reporting period before goodwill, profit / loss from associates, profit / loss on foreign exchange differences arising on financial performance and profit / loss on operations with derivative financial instruments. Adjusted EBITDA is operating profit before depreciation and amortization and financial results of operations with derivative financial instruments. In accordance with International Financial Reporting Standards ("IFRS"), depreciation and amortization are included in cost structure, and in the selling, general and administrative expenses. IFRS does not require the disclosure and does not describe the calculation of EBITDA and adjusted EBITDA, among other financial indicators, so they can not substitute for net profit for the period when evaluating the results of operations or the measure of cash provided by operating activities when evaluating liquidity. Approach to the calculation of EBITDA and adjusted EBITDA, as described earlier, may not coincide with the approaches used by other companies, therefore, comparability may be limited. We believe that EBITDA and adjusted EBITDA provide useful information to investors because they are indicators of the stability and efficiency of our business and our ability to fund discretionary spending such as capital expenditures, the acquisition of subsidiaries and other investments, as well as indicators of our ability to incur and service debt. IFRS classifies depreciation and amortization to operating costs, while in fact they are distributed to the current period non-cash expenses for the acquisition or creation of fixed assets, incurred in previous periods, and are not affiliated with the movement of funds.

Calculation of EBITDA for the first nine months of 2013 and for the first nine months of 2012 (mln RUB)


9 months of 2013
9 months of 2012

Net profit
10,082.9
18,818.2

Add:
Income tax
Interest and other financial income
Interest and other financial costs
Amortisation


1,744.2
2,977.9

(558.6)
(364.9)

1,746.0
1,870.9

2,690.1
2,455.7

Gain of associates
(17.9)
(12.3)

Gain on change in fair value of the share in the associate
0
(4,940.8)

Foreign exchange loss (gain) from financing activities
1,628.3
(1,254.9)

Adjusted EBITDA
17,315.0
19,550.0